Pierre Mordant

Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)

Sylvain Beurtheret, Pierre Mordant, Xavier Paolettí et al. · European Heart Journal · 2012 · 270 citations · Full text

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study

Guillaume Lebreton, Matthieu Schmidt, Maharajah Ponnaiah et al. · The Lancet Respiratory Medicine · 2021 · 251 citations · Full text

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro

Audrey Joannes, Stéphanie Brayer, Valérie Besnard et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2016 · 109 citations

Antifibrotic Therapy, Inflammatory Lung Disease, Lung Inflammation +18

Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation

Pierre Mordant, Daisuke Nakajima, Ricardo Kalaf et al. · The Journal of Heart and Lung Transplantation · 2016 · 104 citations

Regenerative Medicine, Cell Therapy, Transplantation +13